METHOD FOR TREATING THE CASES OF LUNG CANCER

FIELD: medicine. ^ SUBSTANCE: method involves applying surgical intervention and postoperative chemotherapy and radiation treatment. Mediastinal pleura is retained, thoracic wall is pierced in the second intercostals space on parasternal line and thin perforated polyvinylchloride rod, set in mediast...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ZIN'KOVICH S.A, RUBTSOV V.R, ROZENKO L.JA, KARNAUKHOVA E.A, SIDORENKO JU.S
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, ORSURGICAL ARTICLES DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY DIAGNOSIS DISINFECTION, STERILISATION, OR DEODORISATION OF AIR ELECTROTHERAPY HUMAN NECESSITIES HYGIENE IDENTIFICATION MAGNETOTHERAPY MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICALARTICLES MEDICAL OR VETERINARY SCIENCE METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS INGENERAL PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES RADIATION THERAPY SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SURGERY ULTRASOUND THERAPY
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine. ^ SUBSTANCE: method involves applying surgical intervention and postoperative chemotherapy and radiation treatment. Mediastinal pleura is retained, thoracic wall is pierced in the second intercostals space on parasternal line and thin perforated polyvinylchloride rod, set in mediastinum via cut in the mediastinal pleura, is introduced into the pleural cavity in carrying out surgical intervention. The pleura is sutured with catheter fixed therein and external catheter end is fastened with ligature to anterior chest wall skin. Antitumor radiosensibilizer chemopreparations are introduced via the catheter daily beginning from the seventh-eighths day of postoperative period during three days. Distant gamma-therapy is concurrently administered in mobile mode at a dose of 2 Gr twice a day with 4-5 h long pauses during 7 days. The treatment is continued after 2-weeks long pause at a dose of 4 Gr three times a week, with total number of 6 fractions and with antitumor preparations introduced via catheter into the mediastinum or without it depending on treatment results. ^ EFFECT: enhanced effectiveness in delivering radiosensibilizer preparations to an area under radiation treatment; reduced radiation load; reduced risk of complications.